Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Zuckerberg Donates $25M To U.S. Ebola Efforts

News outlets report on Facebook co-founder and CEO Mark Zuckerberg’s donation of $25 million to the U.S. Centers for Disease Control and Prevention Foundation’s Ebola fund. The Hill: Zuckerberg gives $25M to CDC Ebola fund (Hattem, 10/14). PBS NewsHour: Mark Zuckerberg to give $25M to fight Ebola (Morris, 10/14). USA TODAY:…

Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).

International Entities Helping To Prevent HIV Drug Shortage In India

Reuters: Pharmaceutical companies, WHO help India in HIV/AIDS drug crisis “Indian companies and global health groups are stepping up efforts to provide a critical medicine for the country’s free HIV/AIDS drugs program after more than 150,000 patients risked going without their dosages this month. Delayed tender approvals and poor coordination…

Tackling TB In India Requires Both Public, Private Sector Engagement

The Hindu: Fighting India’s silent epidemic Soumya Swaminathan, director of the National Institute for Research in Tuberculosis in Chennai, and Chapal Mehra, New Delhi-based writer “Over 60 percent of all Indians seek health care in the private sector, according to India’s last National Family Health Survey. … Even though parallel…

Search Is On For New Slate Of Malaria ‘Wonder Drugs’

Devex: Complete cure Martin Edlund, CEO of Malaria No More “…With hundreds of millions of people infected with malaria around the globe every year, effective treatment may be the difference between ending the disease and humanitarian disaster. … Our current front-line treatments for malaria, called artemisinin-based combination therapies, underscore the…

World Bank Launches Public-Private Infrastructure Initiative

Reuters: World Bank launches public-private infrastructure plan “The World Bank on Thursday launched a new initiative that would bring together governments, development institutions, and private investors to form public-private partnerships for infrastructure. The initiative, known as the Global Infrastructure Facility, would structure projects to attract long-term investors such as pension…

Grand Challenges Encourage Global Health Innovation

News outlets report on the Grand Challenges, which invite innovators to develop novel technologies to solve global health problems. The Economist: Global health: A new challenge “Ten years ago the Bill & Melinda Gates Foundation began divvying up the money for what it hoped would be a novel approach to…

Ebola Raises Questions On Incentives For Drug, Vaccine Research

TIME: Ebola Should Change How We Fund Drugs for Emerging Disease “Emerging and infectious diseases are having a moment for all the worst reasons, with credit due to the Ebola outbreak. But scientists studying other emerging diseases beyond Ebola are hopeful that the attention on the disease — and what…

Financial Times Examines Ebola’s Potential Economic Impact In West Africa

Financial Times: Ebola is one of several risks facing West Africa “…The predictions of economic losses [from Ebola] vary from apocalyptic billions of dollars in the worse-case scenario to only a few millions of dollars if the outbreak if stopped soon. … Regardless of the final toll, what is already…